Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

~46 mi. (Marborn, Germany, +137 more cities)

Universitatsklinikum Giessen und Marburg GmbH ( Site 0413)

Skin Squamous Cell Carcinoma

pembrolizumab

immunotherapy

Study of ASTX727 vs IV Decitabine in MDS, CMML, and AML

~46 mi. (Marborn, Germany, +74 more cities)

Philipps-Universität Marburg, Klinik für Innere medizin, Hämatologie, Onkologie und Immunologie

Acute Myeloid Leukemia, +4 more conditions

decitabine, +1 more drug

chemotherapy

Dose-escalating Trial With UniCAR02-T Cells and CD123 Target Module (TM123) in Patients With Hematologic and Lymphatic Malignancies

~46 mi. (Marborn, Germany, +5 more cities)

Philipps-Universität Marburg

IL3RA Expression

Acute Myeloid Leukemia, +2 more conditions

cyclophosphamide, +2 more drugs

chemotherapy, +1 more type

Sacituzumab Govitecan in Primary HER2-negative Breast Cancer

~48 mi. (Suhl, Germany, +94 more cities)

SRH Zentralklinikum Suhl

HER2 Negative

Breast Carcinoma

sacituzumab govitecan

chemotherapy, +1 more type

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)

~60 mi. (Kassel, Germany, +57 more cities)

GSK Investigational Site

Non-Squamous Non-Small Cell Lung Carcinoma, +1 more condition

cobolimab, +7 more drugs

chemotherapy, +2 more types

A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)

~70 mi. (Immenhausen, Germany, +172 more cities)

Lungenfachklinik Immenhausen

RET Fusion

Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)

~71 mi. (Erfurt, Germany, +93 more cities)

Helios Klinikum Erfurt GmbH ( Site 1315)

Clear Cell Renal Cell Carcinoma

belzutifan, +1 more drug

targeted therapy

A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer

~73 mi. (Gießen, Germany, +144 more cities)

GSK Investigational Site

Endometrial Carcinoma

carboplatin, +3 more drugs

chemotherapy, +2 more types

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

~73 mi. (Gießen, Germany, +228 more cities)

Universitaetsklinikum Giessen /ID# 231856

MET Expression

Non-Small Cell Lung Carcinoma

telisotuzumab vedotin

chemotherapy, +1 more type

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

~73 mi. (Gießen, Germany, +75 more cities)

Universitaetsklinikum Giessen und Marburg GmbH ( Site 0411)

Classical Hodgkin Lymphoma

bleomycin, +9 more drugs

chemotherapy, +2 more types

AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients With EGFRmutated/T790M Mutation Negative Nonsquamous NSCLC

~73 mi. (Gießen, Germany, +9 more cities)

Universitätsklinikum Gießen Marburg

EGFR Mutation

Non-Squamous Non-Small Cell Lung Carcinoma

afatinib, +2 more drugs

targeted therapy

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

~76 mi. (Göttingen, Germany, +226 more cities)

Universitaetsklinikum Goettingen ( Site 0345)

Prostate Adenocarcinoma

enzalutamide, +1 more drug

hormone therapy, +1 more type